DE60118483T2 - Feste Zubereitung für die Dialyse sowie Verfahren zu deren Herstellung - Google Patents
Feste Zubereitung für die Dialyse sowie Verfahren zu deren Herstellung Download PDFInfo
- Publication number
- DE60118483T2 DE60118483T2 DE60118483T DE60118483T DE60118483T2 DE 60118483 T2 DE60118483 T2 DE 60118483T2 DE 60118483 T DE60118483 T DE 60118483T DE 60118483 T DE60118483 T DE 60118483T DE 60118483 T2 DE60118483 T2 DE 60118483T2
- Authority
- DE
- Germany
- Prior art keywords
- particles
- composition
- dialysis
- sugar
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title claims description 95
- 238000000502 dialysis Methods 0.000 title claims description 56
- 239000007787 solid Substances 0.000 title claims description 53
- 238000000034 method Methods 0.000 title claims description 20
- 239000000203 mixture Substances 0.000 claims description 87
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 56
- 239000002245 particle Substances 0.000 claims description 55
- 235000000346 sugar Nutrition 0.000 claims description 39
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 38
- 239000007771 core particle Substances 0.000 claims description 38
- 239000003792 electrolyte Substances 0.000 claims description 31
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 29
- 238000002156 mixing Methods 0.000 claims description 28
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 28
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 28
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 26
- 239000002253 acid Substances 0.000 claims description 24
- 239000007864 aqueous solution Substances 0.000 claims description 24
- 239000011780 sodium chloride Substances 0.000 claims description 19
- 239000001632 sodium acetate Substances 0.000 claims description 18
- 235000017281 sodium acetate Nutrition 0.000 claims description 18
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 16
- 239000011247 coating layer Substances 0.000 claims description 16
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 14
- 239000001103 potassium chloride Substances 0.000 claims description 14
- 235000011164 potassium chloride Nutrition 0.000 claims description 14
- 239000001110 calcium chloride Substances 0.000 claims description 13
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 13
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 12
- 235000011148 calcium chloride Nutrition 0.000 claims description 10
- 235000011147 magnesium chloride Nutrition 0.000 claims description 10
- 238000005507 spraying Methods 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 20
- 239000008103 glucose Substances 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000005469 granulation Methods 0.000 description 12
- 230000003179 granulation Effects 0.000 description 12
- 239000007788 liquid Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 229960000583 acetic acid Drugs 0.000 description 9
- 229960002713 calcium chloride Drugs 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 229960002337 magnesium chloride Drugs 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 229960002816 potassium chloride Drugs 0.000 description 7
- -1 Calcium chloride anhydride Chemical class 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229960004249 sodium acetate Drugs 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical group O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 4
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 4
- 238000002845 discoloration Methods 0.000 description 4
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 description 4
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 4
- 238000005550 wet granulation Methods 0.000 description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- 238000007908 dry granulation Methods 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- CZMRCDWAGMRECN-UHFFFAOYSA-N 2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000001631 haemodialysis Methods 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 229960002668 sodium chloride Drugs 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- YMIFCOGYMQTQBP-UHFFFAOYSA-L calcium;dichloride;hydrate Chemical compound O.[Cl-].[Cl-].[Ca+2] YMIFCOGYMQTQBP-UHFFFAOYSA-L 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011973 solid acid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- External Artificial Organs (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000293329A JP3899506B2 (ja) | 2000-09-27 | 2000-09-27 | 固形透析用製剤およびその製造方法 |
| JP2000293329 | 2000-09-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60118483D1 DE60118483D1 (de) | 2006-05-18 |
| DE60118483T2 true DE60118483T2 (de) | 2006-10-19 |
Family
ID=18776140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60118483T Expired - Lifetime DE60118483T2 (de) | 2000-09-27 | 2001-09-24 | Feste Zubereitung für die Dialyse sowie Verfahren zu deren Herstellung |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US6923987B2 (https=) |
| EP (1) | EP1192961B1 (https=) |
| JP (1) | JP3899506B2 (https=) |
| DE (1) | DE60118483T2 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1523350B1 (en) | 2002-07-19 | 2011-04-13 | Baxter International Inc. | System for performing peritoneal dialysis |
| WO2004067014A1 (ja) * | 2003-01-31 | 2004-08-12 | Manac Inc. | 透析用固形剤およびその製造方法 |
| WO2004066977A1 (ja) * | 2003-01-31 | 2004-08-12 | Manac Inc. | 透析用固形剤及びその製造方法 |
| CN100558344C (zh) * | 2004-02-09 | 2009-11-11 | 尼普洛株式会社 | 透析用固体制剂及其制造方法 |
| US20070231395A1 (en) * | 2004-03-30 | 2007-10-04 | Toshiya Kai | Solid Pharmaceutical Preparation for Dialysis |
| JP2007032601A (ja) * | 2005-07-22 | 2007-02-08 | Inaba Denki Sangyo Co Ltd | 貫通孔閉塞具及びそれを用いた貫通孔閉塞構造 |
| TWI516284B (zh) | 2007-05-31 | 2016-01-11 | 味之素股份有限公司 | 透析用固態製劑 |
| US7736328B2 (en) | 2007-07-05 | 2010-06-15 | Baxter International Inc. | Dialysis system having supply container autoconnection |
| US7892423B2 (en) | 2008-02-14 | 2011-02-22 | Baxter International Inc. | Dialysis system including multi-heater power coordination |
| US10973968B2 (en) | 2008-02-14 | 2021-04-13 | Baxter International Inc. | Control of a water device via a dialysis machine user interface |
| US8057679B2 (en) | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
| PL2585039T3 (pl) | 2010-06-23 | 2018-09-28 | Gambro Lundia Ab | Kompozycja prekursorowa do dializy |
| ES2535867T3 (es) | 2010-06-23 | 2015-05-18 | Gambro Lundia Ab | Composición precursora de diálisis |
| DE102010039489A1 (de) | 2010-08-18 | 2012-02-23 | Fresenius Medical Care Deutschland Gmbh | Konzentrat |
| AU2012272022B2 (en) | 2011-06-20 | 2015-04-02 | Gambro Lundia Ab | Dialysis precursor composition |
| ES2587862T3 (es) | 2011-06-20 | 2016-10-27 | Gambro Lundia Ab | Composición precursora de diálisis |
| PL2793903T3 (pl) | 2011-12-21 | 2018-12-31 | Gambro Lundia Ab | Kompozycja prekursorowa do dializy |
| PL2793902T3 (pl) | 2011-12-21 | 2018-11-30 | Gambro Lundia Ab | Kompozycja prekursorowa do dializy |
| SE536913C2 (sv) | 2012-03-08 | 2014-10-28 | Gambro Lundia Ab | Komposition för dialys |
| AU2013201546B2 (en) | 2012-12-18 | 2014-10-23 | Gambro Lundia Ab | Dialysis composition |
| EP2905039A1 (en) * | 2014-02-07 | 2015-08-12 | Fresenius Medical Care Deutschland GmbH | Dry Acid Concentrate in Granulate form |
| US10105299B2 (en) * | 2014-04-10 | 2018-10-23 | The Research Foundation for The State University o f New York | Method of using sonochemical activaction to form meta-stable substances |
| CN104586884A (zh) * | 2015-01-09 | 2015-05-06 | 李淑秀 | 新型血液透析浓缩液 |
| ES2987653T3 (es) | 2015-06-25 | 2024-11-15 | Gambro Lundia Ab | Sistema y método de dispositivo médico que tiene una base de datos distribuida |
| WO2017193065A1 (en) | 2016-05-06 | 2017-11-09 | Gambro Lundia Ab | Systems and methods for peritoneal dialysis having point of use dialysis fluid preparation including testing thereof |
| WO2018114346A1 (en) | 2016-12-21 | 2018-06-28 | Gambro Lundia Ab | Medical device system including information technology infrastructure having secure cluster domain supporting external domain |
| CN109223822A (zh) * | 2018-11-16 | 2019-01-18 | 秦皇岛迈淩医疗设备有限公司 | 一种血液透析用固体制剂及其制备方法 |
| CN111943234A (zh) * | 2020-08-13 | 2020-11-17 | 河北华晨药业有限公司 | 一种制备大粒径药用级无菌碳酸氢钠颗粒的方法 |
| JP7450957B2 (ja) * | 2022-04-08 | 2024-03-18 | 富田製薬株式会社 | 血液透析用ａ剤及び血液透析用剤 |
| JP7653748B1 (ja) * | 2023-09-07 | 2025-03-31 | 富田製薬株式会社 | 血液透析用ａ剤及び血液透析用剤 |
| WO2025144780A1 (en) | 2023-12-27 | 2025-07-03 | Baxter International Inc. | Solid pharmaceutical preparation for peritoneal dialysis and process for producing the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4756838A (en) * | 1980-02-21 | 1988-07-12 | Veltman Preston Leonard | Preparation of dry dialysate products |
| US4784495A (en) * | 1987-02-06 | 1988-11-15 | Gambro Ab | System for preparing a fluid intended for a medical procedure by mixing at least one concentrate in powder form with water |
| AU627309B2 (en) * | 1989-05-26 | 1992-08-20 | Terumo Kabushiki Kaisha | Preparation for blood dialysis and method for production thereof |
| JP2769592B2 (ja) * | 1992-12-14 | 1998-06-25 | 富田製薬株式会社 | 重炭酸透析用人工腎臓灌流用剤の製造方法及び人工腎臓灌流用剤 |
| JP2002102336A (ja) * | 2000-09-27 | 2002-04-09 | Nipro Corp | 固形透析用製剤およびその製造方法 |
-
2000
- 2000-09-27 JP JP2000293329A patent/JP3899506B2/ja not_active Expired - Lifetime
-
2001
- 2001-09-24 DE DE60118483T patent/DE60118483T2/de not_active Expired - Lifetime
- 2001-09-24 EP EP01122540A patent/EP1192961B1/en not_active Expired - Lifetime
- 2001-09-27 US US09/963,570 patent/US6923987B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1192961A2 (en) | 2002-04-03 |
| JP3899506B2 (ja) | 2007-03-28 |
| US6923987B2 (en) | 2005-08-02 |
| EP1192961A3 (en) | 2002-08-07 |
| US20020061338A1 (en) | 2002-05-23 |
| EP1192961B1 (en) | 2006-04-05 |
| DE60118483D1 (de) | 2006-05-18 |
| JP2002102337A (ja) | 2002-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60118483T2 (de) | Feste Zubereitung für die Dialyse sowie Verfahren zu deren Herstellung | |
| DE60009791T2 (de) | Feste pharmazeutische Zubereitung für die Dialyse sowie Verfahren zu deren Herstellung | |
| DE69022884T2 (de) | Zubereitung für die Hemodialyse und deren Produktionsmethode. | |
| DE2749751C3 (de) | Verfahren zur Konservierung von Schmelzkäse | |
| DE60101192T2 (de) | Feste Zubereitung für die Dialyse und Herstellungsverfahren hierfür | |
| DE69531957T2 (de) | Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung | |
| DE69407404T2 (de) | Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung | |
| DE69313798T2 (de) | Dialysatkomponente für die Bicarbonatdialyse und Methode zu seiner Herstellung | |
| DE60105807T2 (de) | Verfahren zur Herstellung einer stabilen pharmazeutischen Zusammensetzung enthaltend mikronisiertes Formoterol | |
| DE2725390C2 (https=) | ||
| DE69705106T2 (de) | Darmreiniger auf Basis von umhülltem Natriumphosphat | |
| DE3435516A1 (de) | Massen zur ausbildung von vesikeln | |
| DE2058434A1 (de) | Freifliessende,leicht benetzbare Acetylsalicylsaeure enthaltende Teilchen | |
| DE1930957B2 (de) | Wasserlösliches Silbersalz ent haltendes Gel zur Behandlung von Ver brennungen | |
| DE69102900T2 (de) | Brausemischung, deren Herstellung sowie Verwendung. | |
| DE69624364T2 (de) | Abführmittel enthaltend lactitol und psyllium | |
| DE1542340A1 (de) | Verfahren zur UEberfuehrung fein zerteilter,fester Substanzen in frei fliessende Form | |
| DE69734532T2 (de) | Futterzusätze für wiederkäuer | |
| CH640731A5 (de) | Ueberzugsmittel fuer feste medikamente. | |
| DE2639505B2 (https=) | ||
| DE3324209A1 (de) | Suloctidil enthaltende, oral verabfolgbare arzneimittel mit verzoegerter wirkstoffabgabe | |
| DE60009414T2 (de) | Natiumbikarbonat enthaltende feste Arzneistoffzubereitung zur Dialyse und Verfahren zum Herstellung derselben | |
| DE10221863A1 (de) | Phospholipidische Zusammensetzung sowie deren Verwendung | |
| DE69209228T2 (de) | Acetazolamide Formulierung mit verzögerter Wirkstoffabgabe | |
| DE1097963B (de) | Verfahren zur Herstellung von nicht hygroskopischen frei fliessenden, kondensierten glasigen Phosphaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |